CN Patent
CN103974700B — 贴附剂
Assigned to Hisamitsu Pharmaceutical Co Inc · Expires 2015-12-09 · 10y expired
What this patent protects
本发明是一种贴附剂,其具备支持体层与粘着剂层,上述粘着剂层含有双氯芬酸或其可药用的盐、甘油、丁二醇及聚乙二醇单油酸酯,并且上述丁二醇与上述聚乙二醇单油酸酯的质量比(丁二醇的质量∶聚乙二醇单油酸酯的质量)为1∶1~4∶1。
USPTO Abstract
本发明是一种贴附剂,其具备支持体层与粘着剂层,上述粘着剂层含有双氯芬酸或其可药用的盐、甘油、丁二醇及聚乙二醇单油酸酯,并且上述丁二醇与上述聚乙二醇单油酸酯的质量比(丁二醇的质量∶聚乙二醇单油酸酯的质量)为1∶1~4∶1。
Drugs covered by this patent
- Saphris (ASENAPINE) · Hisamitsu
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.